|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 活性氧化铝除氟研究显示文摘针对目前活性氧化铝饮水除氟中存在的问题,进行了生产性试验研究,通过采用原水投加CO_2气体降低pH值、小颗粒活性氧化铝、大流量短历时的NaOH循环再生法等新技术,提高了活性氧化铝的吸附容量和处理水的能力,克服滤料板结和假疲劳,除氟效果稳定可靠,水质好,再生时间短,用药省,降低了基建投资和运转费用。 | North China Municipal Engineering Design Institute A full-scale plant was set up for studying the existing problems on the fluoride removal from drinking water by activated alumina. Some new methods was adopted,such as the addition of CO2to reduce water pH value,the use of small-sized activated alumina,and the employment of a cyclic regeneration at large flow rate with NaOH as regenerant,which result in the improvement of adsorption capacity of activated alumina and treatment capacity, the elimination of the hardening of filtration materials and false fatigue,stable and reliable effectiveness,good quality in water,short regeneration time,small consumption of regenerant. And then the capital and openational costs were reduced. | 1989 | 中国给水排水1989，5，3： | 5 |
| 2 | Random- ized study of a short course of weekly cisplatin with or with- out amifostine in advanced head and neck cancer显示文摘 | Planting AS Catimel G de Mulder PH | 1999 | Ann Oncol1999，10，6： | 1 |
| 3 | Dynamics of the follicle-stimulating hormone (FSH)-inhibin B feedback loop and its role in regulating spermatogenesis in the adult rhesus monkey (Macaca mulatta) as revealed by unilateral orchidectomy显示文摘 | Marshall GR McNeilly AS Plant TM | 2000 | Endocrinology2000，141，： | 1 |
| 4 | Treatment of patients wiehastatic pancreatic and gastrointestinal tumors with thsomatostatin analogue Sandostatin a phase Ⅱ study including endocrine effocts显示文摘 | Klijn J Hoff AM Planting AS | 1990 | Br J Cancer1990，62，： | 1 |
| 5 | Phase I and phamacological study of intemittent twice - daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer 显示文摘 | Mackean MJ Planting AS Twelves C | 1998 | J Clin Oncol1998，16，29： | 1 |
| 6 | Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metaastatic squamous cell carcinoma of the head and neck 显示文摘 | Schoffski P Catimel G Planting AS | 1999 | Ann Oncol1999，10，： | 1 |
| 7 | The potential of statins as part of anti-cancer treatment显示文摘 | Sleijfer S van der Gaast A Planting AS | | 0，，04： | 1 |
| 8 | Real-time pharmacokinetics guiding clinical decisions;phase I study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumours 显示文摘 | Soepenberg O Sparreboom A De Jonge MJ Planting AS De Heus G Loos WJ | 2004 | Eur JCancer2004，40，： | 1 |
| 9 | A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours显示文摘 | ESKENS FA MOM CH PLANTING AS | 2008 | Br J Cancer2008，98，1： | 1 |
| 10 | Treatment of patients with metastatic pancreatic and gastrointestinal turnouts with the somatostatin analogue Sandostatin: a phase 11 study including endocrine effects显示文摘 | Klijn JG Hoff AM Planting AS Verweij J Kok T Lamberts SW Portengen H Foekens JA | 1990 | Br J Cancer1990，62，4： | 1 |
| 11 | The value of immunohistochemistry in patients with poorly differentiated ad and undifferentiated carcinomas of unknown primary 显示文摘 | van der Gaast A Verwij J Planting AS | 1996 | J Cancer Res Clin Oncol1996，122，： | 1 |
| 12 | Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer显示文摘 | Catimel G de Mulder Ph | 1999 | EORTC Ann Oncol1999，10，6： | 1 |
| 13 | A phase I doseescalation study of BIBW 2992 , an irreversible dual inhibitor ofepidermal growth factor receptor 1 ( EGFR) and 2 ( HER2) tyro-sine kinase in a 2-week on,2-week off schedule in patients withadvanced solid tumours显示文摘 | ESKENS FA MOM CH PLANTING AS ^ al | 2008 | Br J Cancer2008，98，1： | 1 |
| 14 | A Phase I and pharmacologic study of intermittent twice daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer 显示文摘 | Planting AS Twelves C | 1998 | J Clin Oncol1998，16，： | 1 |
| 15 | A phase I dose escalation study of BIBW 2992,an irreversible dual inhibitor of epidermal growth factor receptor I (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on,2-week off schedule in patients with advanced solid tumours显示文摘 | Eskens FA Mom CH Planting AS | | 0，，1： | 1 |
| 16 | Phase Ⅰ and pharmaeo logieal study of intermittent twicedaily oral therapy with eapeeitabine in patients with advanced and/or metastatic cancer 显示文摘 | Maekean M J Planting AS Twelves C | 1998 | J Clin Oncol1998，16，： | 1 |
| 17 | A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors显示文摘 | Planting AS Sonneveld P van der Gaast A | 2005 | Cancer Chemother Pharmacol2005，55，1： | 1 |
| 18 | Phase Ⅰ and pharmacologic study of the novel indoloquinonebioreductive alkylating cytotoxic drug EO9显示文摘 | SCHELLENS JH PLANTING AS VAN ACKER BA | 1994 | J Natl Cancer Inst1994，86，12： | 1 |
| 19 | A phase I dose escalation study of BIBW 2992,an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on,2-week off schedule in patients with advanced solid tumours显示文摘 | Eskens FA Mom CH Planting AS | 2008 | Br J Cancer2008，98，： | 1 |
| 20 | Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury显示文摘 | Kramer AS Harvey AFt Plant GW | 2013 | Cell Transplant2013，22，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员